Mualliflar

  • Эргашева Д.Ш.
  • Турсунбаева Ф.Ф.

##semicolon##

неинвазивный пренатальный тестинг (НИПТ), cell-free DNA (cfDNA), ложноположительный результат, плацентарный мозаицизм, материнский мозаицизм, исчезнувший близнец, материнская злокачественная опухоль, анеуплоидия.

##submission.citations##

1. Raymond Y, Fernando S, Menezes M, Mol BW, McLennan A, da Silva Costa F, Hardy T, Rolnik DL. Placental, maternal, fetal, and technical origins of false-positive cell-free DNA screening results. Am J Obstet Gynecol. 2024;230(4):381-389. DOI: 10.1016 /j.ajog.2023.11.1240. PMID:38008147.

2. Norton ME. Cell-free DNA Screening for Aneuploidy. Clin Obstet Gynecol. 2023;66(3):557-567. DOI:10.1097/GRF.0000000000000796. PMID: 37650668.

3. Rosenblum J, Blaumeiser B, Janssens K. The impact of confined placental mosaicism on prenatal cell-free DNA screening: Insights from a monocentric study of 99 cases. Placenta. 2024; 152:17-22. DOI: 10.1016/j.placenta.2024.04.012. PMID:387 44036.

4. Kónya M, Czimbalmos Á, Éliás M, Tidrenczel Z, Kói T, Pinto Amorim das Virgens I, Ács N, Nyirády P, Hegyi P, Várbíró S, Gál A. Discordant findings in genome-wide noninvasive prenatal testing for rare chromosomal abnormalities, adverse pregnancy outcomes, and maternal malignancies: a systematic review and meta-analysis. Am J Obstet Gynecol. 2026;234(5):1342-1354. DOI: 10.1016/ j. ajog.2025.11.029. PMID:41297782.

5. Xiang J, Li R, He J, Wang X, Yao L, Song N, Fu F, Zhou S, Wang J, Gao X, Peng J, Wan J, Hu L, Liu A, Guo Y, Peng C, Liu X, Lin J, Li S, Sun J, Li D, Peng Z, Liao C. Clinical impacts of genome-wide noninvasive prenatal testing for rare autosomal trisomy. Am J Obstet Gynecol MFM. 2023;5(1):100790. doi: 10.1016/ j.ajogmf.2022.100790. PMID:36377092.

6. Rolnik DL, Raymond Y, Lee T, Ramkrishna J, da Silva Costa F, Menezes M, Meagher S. Uterine fibroids and non-informative cell-free DNA screening results. Ultrasound Obstet Gynecol. 2024;64(4):463-469. DOI:10.1002/uog.29098. PMID:39177335.

7. Raymond Y, Fernando S, Menezes M, Mol BW, Brown E, Arnold K, Rolnik DL. Placental cytogenetic testing for confined placental mosaicism and obstetrical outcomes after discordant cell-free DNA screening results. Am J Obstet Gynecol MFM. 2026;8 (3):101887. DOI: 10.1016/j.ajogmf.2025.101887. PMID:41520802.

8. Flowers NJ, Love CJ, Scarff KL, Giouzeppos O, Archibald AD, Delatycki MB, Pertile MD. Assessment of Placental Chromosomal Mosaicism during Prenatal Cell-Free DNA Screening Refines Positive Predictive Values for Fetal Trisomy. Clin Chem. 2025; 71(10):1036-1046. DOI:10.1093/clinchem/hvaf076. PMID:40720098.

9. Van Eekhout JCA, Bax CJ, van Prooyen Schuurman L, Becking EC, van der Ven AJEM, Van Opstal D, Boon EMJ, Macville MV, Bekker MN, Galjaard RJH; Dutch NIPT Consortium. Performance of non-invasive prenatal testing in vanishing-twin and multiple pregnancies: results of TRIDENT-2 study. Ultrasound Obstet Gynecol. 2025;66(6):738-746. DOI:10.1002/uog.70015. PMID:40913805.

10. Snyder MW, Simmons LE, Kitzman JO, Coe BP, Henson JM, Daza RM, Eichler EE, Shendure J, Gammill HS. Copy-number variation and false positive prenatal aneuploidy screening results. N Engl J Med. 2015;372(17):1639-1645. DOI:10.1056/NEJMoa14 08408. PMID:25830323.

11. Rink BD, Stevens BK, Norton ME. Incidental Detection of Maternal Malignancy by Fetal Cell-Free DNA Screening. Obstet Gynecol. 2022; 140(1):121-131. DOI:10.1097/AOG.000000000000 4833. PMID:35849469.

12. Lenaerts L, Theunis M, Amant F, Vermeesch JR. Non-invasive prenatal testing: when results suggests maternal cancer. Med Genet. 2023; 35(4):285-295. doi:10.1515/medgen-2023-2055. P-MID:38835737.

13. Santoli CMA, Anastasio MK, Sparks TN, Dotters-Katz SK, Kuller JA. Unusual Maternal and Fetal Findings With Cell-Free DNA Screening. Obstet Gynecol Surv. 2024;79(9):539-546. doi:10.1097/OG X.0000000000001297. PMID:39288158.